Cargando…
Myopia Control with Low-Dose Atropine in European Children: Six-Month Results from a Randomized, Double-Masked, Placebo-Controlled, Multicenter Study
The effect and safety of low-dose atropine in myopia control have not been studied in randomized, placebo-controlled trials outside Asia. We investigated the efficacy and safety of 0.1% atropine loading dose and 0.01% atropine compared with a placebo in a European population. Investigator-initiated,...
Autores principales: | Hvid-Hansen, Anders, Jacobsen, Nina, Møller, Flemming, Bek, Toke, Ozenne, Brice, Kessel, Line |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9960354/ https://www.ncbi.nlm.nih.gov/pubmed/36836559 http://dx.doi.org/10.3390/jpm13020325 |
Ejemplares similares
-
Safety and efficacy of 0.01% and 0.1% low-dose atropine eye drop regimens for reduction of myopia progression in Danish children: a randomized clinical trial examining one-year effect and safety
por: Hansen, Niklas Cyril, et al.
Publicado: (2023) -
Low-Dose Atropine Induces Changes in Ocular Biometrics in Myopic Children: Exploring Temporal Changes by Linear Mixed Models and Contribution to Treatment Effect by Mediation Analyses
por: Hvid-Hansen, Anders, et al.
Publicado: (2023) -
Topical Atropine in the Control of Myopia
por: GALVIS, Virgilio, et al.
Publicado: (2016) -
Biological Mechanisms of Atropine Control of Myopia
por: Upadhyay, Aradhana, et al.
Publicado: (2020) -
Myopia Outcome Study of Atropine in Children (MOSAIC): an investigator-led, double-masked, placebo-controlled, randomised clinical trial protocol
por: McCrann, Saoirse, et al.
Publicado: (2019)